AbbVie Invests $380M to Expand Illinois Manufacturing for Neuroscience, Obesity Meds
Insurance Journal - Feb 24, 2026
AbbVie on Monday said it would invest $380 million to build two new active pharmaceutical ingredient manufacturing facilities at its Illinois campus, expanding its domestic production capacity for its neuroscience and obesity medicines. The investment is part of AbbVie’s broader …...
Recommended Articles
Posted: Apr 16, 2026
The medical officer for the Texas summer camp where 27 girls were killed in a flood last year testif...
Posted: Apr 16, 2026
Utah-based insurance broker Trucordia reports it has acquired the Paradiso Financial and Insurance S...
Posted: Apr 16, 2026
Inszone Insurance Services announced the acquisition of Insurance Resources Group, Inc. Located in O...